Source BioScience is a Biotechnology company with an expertise in the development and validation of biomarkers for use as companion diagnostics to support new drug launches or as endpoints for clinical and FDA studies.

 We also provide pharmacogenomic and clinical  testing services, supporting pre-clinical & clinical trials for different therapeutic areas, with an expertise in Cancer.

The emerging interest in "pharmacogenomics" is comprehensively covered to aid  the clinical development of new diagnostic, prognostic and predictive tests as well as supporting drug development pipeline studies from target identification through to clinical trials.

Source BioScience is GLP, GCP and CPA accredited with five laboratories throughout the UK and Eire providing global clinical trial support and is the biggest genomics and pathology  service provider in the UK.